The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Omega-3 Fatty Acid Supplementation for the Treatment of Children With Attention-Deficit/Hyperactivity Disorder Symptomatology: Systematic Review and Meta-Analysis
Open accessAbstract
Objective Several studies have demonstrated differences in omega-3 fatty acid composition in plasma and in erythrocyte membranes in patients with ADHD compared to unaffected controls. Omega-3 fatty acids have anti-inflammatory properties and can alter central nervous system cell membrane fluidity and phospholipid composition. Cell membrane fluidity can alter serotonin and dopamine neurotransmission. The goal of this meta-analysis is to examine the efficacy of omega-3 fatty acid supplementation in children with ADHD. Method We searched PubMED for randomized, placebo-controlled trials examining omega-3 fatty acid supplementation in children with ADHD symptomatology. Our primary outcome measure was standardized mean difference in rating scales of ADHD severity. We conducted secondary analyses to determine the effects of dosing of different omega-3 fatty acids in supplements. Results Ten trials involving 699 children were included in this meta-analysis. Omega-3 fatty acid supplementation demonstrated a small, but significant effect in improving ADHD symptoms. Eicosapentaenoic acid (EPA) dose within supplements was significantly correlated with supplement efficacy. We found no evidence of publication bias or heterogeneity between trials. Conclusion Omega-3 fatty acid supplementation, particularly with higher doses of EPA, was modestly effective in the treatment of ADHD. The relative efficacy of omega-3 fatty acid supplementation was modest compared to currently available pharmacotherapies for ADHD such as psychostimulants, atomoxetine or alpha-2 agonists. However, given its relatively benign side-effect profile and evidence of modest efficacy, it may be reasonable to use omega-3 fatty supplementation to augment traditional pharmacological interventions or for families who decline other psychopharmacological options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Omega-3 fatty acid supplementation was associated with small-to-medium improvements in ADHD symptoms in three meta-analyses (ten studies with 699 participants, 16 studies with 1,408 participants, 7 studies with 534 participants) (Bloch and Qawasmi, 2011; Chang et al., 2018; Hawkey and Nigg, 2014).”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Bloch and Qawasmi, 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Omega-3 fatty acids in health and disease and in growth and development.
Simopoulos, A. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.438 · Cited by 2,162
Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases
Simopoulos, A. P. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719248 · Cited by 2,057
Moher, D., Jadad, A. R., Nichol, G., Penman, M., Tugwell, P., & Walsh, S. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00031-w · Cited by 1,308
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Committee on Quality Improvement, S. O. A.-D. D. (2000) · Pediatrics · doi:10.1542/peds.105.5.1158 · Cited by 1,076
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1217 · Cited by 709
Omega-3 fatty acids and monoamine neurotransmission
Chalon, S. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.07.005 · Cited by 448
Research works printed but not linked: 1
- Brue, 2001, The use of dietary supplement combination and an essential fatty acid as an alternative and complementary treatment for children with attention-deficit/hyperactivity disorder, Sci Rev Alternative Med, 5, 187
Cited by
Sorted by citations
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545
“1408 participants, 7 studies with 534 participants) (Bloch and Qawasmi, 2011; Chang et al., 2018; Hawkey and Nigg, 2014).”
Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070991 · Cited by 1,167
Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis
Cortese, S., Moreira-Maia, C. R., St. Fleur, D., Morcillo-Peñalver, C., Rohde, L. A., & Faraone, S. V. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020266 · Cited by 606
Feeding the microbiota–gut–brain axis: Diet, microbiome, and neuropsychiatry
Sandhu, K. V., Sherwin, E., Schellekens, H., Stanton, C., Dinan, T. G., & Cryan, J. F. (2017) · Translational Research · doi:10.1016/j.trsl.2016.10.002 · Cited by 491
Nutritional psychiatry: Towards improving mental health by what you eat
Adan, R. A. H., van der Beek, E. M., Buitelaar, J. K., Cryan, J. F., Hebebrand, J., Higgs, S., Schellekens, H., & Dickson, S. L. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.10.011 · Cited by 454
Attention-deficit/hyperactivity disorder
Faraone, S. V., Bellgrove, M. A., Brikell, I., Cortese, S., Hartman, C. A., Hollis, C., Newcorn, J. H., Philipsen, A., Polanczyk, G. V., Rubia, K., et al. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00495-0 · Cited by 355
Neuroplastic changes in depression: A role for the immune system
Eyre, H., & Baune, B. T. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.019 · Cited by 319
Macdonald, K. T., Germine, L. T., Anderson, A., Christodoulou, J. A., & McGrath, L. M. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.01314 · Cited by 275
Black, L. I., Clarke, T. C., Barnes, P. M., Stussman, B. J., & Nahin, R. L. (2015) · PubMed · Cited by 246
Biomarkers and Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analyses
Scassellati, C., Bonvicini, C., Faraone, S. V., & Gennarelli, M. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.08.015 · Cited by 235
Attention‐deficit hyperactivity disorder ( ADHD ): an updated review of the essential facts
Tarver, J., Daley, D., & Sayal, K. (2014) · Child: Care, Health and Development · doi:10.1111/cch.12139 · Cited by 234
Oxidative Stress and ADHD: A Meta-Analysis
Joseph, N., Zhang-James, Y., Perl, A., & Faraone, S. V. (2015) · Journal of Attention Disorders · doi:10.1177/1087054713510354 · Cited by 203
Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data
Bozzatello, P., Brignolo, E., Grandi, E. D., & Bellino, S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5080067 · Cited by 193
Richardson, A. J., Burton, J., Sewell, R. P., Spreckelsen, T. F., & Montgomery, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043909 · Cited by 169
Epigenetic profiling of ADHD symptoms trajectories: a prospective, methylome-wide study
Walton, E., Pingault, J., Cecil, C. A. M., Gaunt, T. R., Relton, C. L., Mill, J. S., & Barker, E. D. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.85 · Cited by 164
Hawkey, E., & Nigg, J. T. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.05.005 · Cited by 160
The Mediterranean Diet and ADHD in Children and Adolescents
Ríos-Hernández, A., Alda, J. A., Farran-Codina, A., Ferreira-García, E., & Izquierdo-Pulido, M. (2017) · PEDIATRICS · doi:10.1542/peds.2016-2027 · Cited by 160
Gillies, D. M., Sinn, J. K. H., Lad, S. S., Leach, M., & Ross, M. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007986.pub2 · Cited by 173
Pediatric Integrative Medicine
McClafferty, H. H., Vohra, S., Bailey, M. L., Brown, M. L., Esparham, A. E., Gerstbacher, D., Golianu, B. J., Niemi, A., Sibinga, E. M. S., Weydert, J. A., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2017-1961 · Cited by 155
Kuratko, C. N., Barrett, E., Nelson, E., & Salem, N. (2013) · Nutrients · doi:10.3390/nu5072777 · Cited by 163
Pelsser, L. M., Frankena, K., Toorman, J., & Rodrigues Pereira, R. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169277 · Cited by 145
Martinat, M., Rossitto, M., Miceli, M. D., & Layé, S. (2021) · Nutrients · doi:10.3390/nu13041185 · Cited by 152
Biomarkers in the Diagnosis of ADHD – Promising Directions
Faraone, S. V., Bonvicini, C., & Scassellati, C. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0497-1 · Cited by 152
Healy-Stoffel, M., & Levant, B. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180412153612 · Cited by 133
Holtmann, M., Sonuga-Barke, E., Cortese, S., & Brandeis, D. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.05.006 · Cited by 128
Agostoni, C. V., Nobile, M., Ciappolino, V., Delvecchio, G., Tesei, A., Turolo, S., Crippa, A., Mazzocchi, A., Altamura, C. A., & Brambilla, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122608 · Cited by 138
Parletta, N., Niyonsenga, T., & Duff, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156432 · Cited by 136
Raine, A., Portnoy, J., Liu, J., Mahoomed, T., & Hibbeln, J. R. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12314 · Cited by 120
Omega-3 Fatty Acid and Nutrient Deficits in Adverse Neurodevelopment and Childhood Behaviors
Gow, R. V., & Hibbeln, J. R. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.02.002 · Cited by 125
Internet-Based, Randomized, Controlled Trial of Omega-3 Fatty Acids for Hyperactivity in Autism
Bent, S., Hendren, R. L., Zandi, T., Law, K., Choi, J., Widjaja, F., Kalb, L. G., Nestle, J., & Law, P. A. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.01.018 · Cited by 127
Omega-3 Fatty Acids in Psychiatry
Mischoulon, D., & Freeman, M. P. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.12.002 · Cited by 116
Bos, D. J., Oranje, B., Veerhoek, E. S., Van Diepen, R. M., Weusten, J. M., Demmelmair, H., Koletzko, B., de Sain-van der Velden, M. G., Eilander, A., Hoeksma, M., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.73 · Cited by 110
β-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels
Chen, C. T., & Bazinet, R. P. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.05.007 · Cited by 110
Cooper, R. E., Tye, C., Kuntsi, J., Vassos, E., & Asherson, P. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115587958 · Cited by 117
Stevenson, J., Buitelaar, J., Cortese, S., Ferrin, M., Konofal, E., Lecendreux, M., Simonoff, E., Wong, I. C. K., & Sonuga‐Barke, E. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12215 · Cited by 106
Widenhorn-Müller, K., Schwanda, S., Scholz, E., Spitzer, M., & Bode, H. (2014) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.04.004 · Cited by 103
Diet in the treatment of ADHD in children—A systematic review of the literature
Rytter, M. J. H., Andersen, L. B. B., Houmann, T., Bilenberg, N., Hvolby, A., Mølgaard, C., Michaelsen, K. F., & Lauritzen, L. (2014) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2014.921933 · Cited by 103
Lim, C. G., Poh, X. W. W., Fung, S. S. D., Guan, C., Bautista, D., Cheung, Y. B., Zhang, H., Yeo, S. N., Krishnan, R. K. R., & Lee, T.-S. W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216225 · Cited by 98
Omega-3 fatty Acids in cardiovascular disease – An uphill battle
von Schacky, C. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.05.004 · Cited by 100
Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
Hashimoto, K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00036 · Cited by 95
Montgomery, P., Burton, J., Sewell, R. P., Spreckelsen, T. F., & Richardson, A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066697 · Cited by 94
Chang, J. P., Su, K., Mondelli, V., Satyanarayanan, S. K., Yang, H.-T., Chiang, Y.-J., Chen, H.-T., & Pariante, C. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0633-0 · Cited by 100
Bos, D. J., van Montfort, S. J. T., Oranje, B., Durston, S., & Smeets, P. A. M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.031 · Cited by 99
McNamara, R. K. (2015) · World Journal of Psychiatry · doi:10.5498/wjp.v5.i1.15 · Cited by 88
Tarver, J., Daley, D., Lockwood, J., & Sayal, K. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0556-5 · Cited by 87
A systematic meta-review of systematic reviews on attention deficit hyperactivity disorder
Chaulagain, A., Lyhmann, I., Halmøy, A., Widding‐Havneraas, T., Nyttingnes, O., Bjelland, I., & Mykletun, A. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2451 · Cited by 97
Villagomez, A., & Ramtekkar, U. P. (2014) · Children · doi:10.3390/children1030261 · Cited by 78
The emerging role of omega-3 fatty acids as a therapeutic option in neuropsychiatric disorders
Reimers, A., & Ljung, H. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319858901 · Cited by 79
Cooper, R. E., Tye, C., Kuntsi, J., Vassos, E., & Asherson, P. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.053 · Cited by 73
Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
Bozzatello, P., Rocca, P., Mantelli, E., & Bellino, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215257 · Cited by 77
Montgomery, P., Burton, J., Sewell, R. P., Spreckelsen, T. F., & Richardson, A. J. (2014) · Journal of Sleep Research · doi:10.1111/jsr.12135 · Cited by 76
Doaei, S., Bourbour, F., Teymoori, Z., Jafari, F., Kalantari, N., Torki, S. A., Ashoori, N., Gorgani, S. N., & Gholamalizadeh, M. (2021) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2020.101806 · Cited by 83
Attention Deficit Hyperactivity Disorder and oxidative stress: A short term follow up study
Güney, E., Çetin, F. H., Alışık, M., Tunca, H., Torun, Y. T., İşeri, E., Taner, Y. I., Çaycı, B., & Erel, Ö. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.003 · Cited by 71
N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology
Pusceddu, M. M., Kelly, P., Stanton, C., Cryan, J. F., & Dinan, T. G. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw078 · Cited by 70
Shareghfarid, E., Sangsefidi, Z. S., Salehi‐Abargouei, A., & Hosseinzadeh, M. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.10.013 · Cited by 75
The Association of Lifestyle Factors and ADHD in Children
Holton, K. F., & Nigg, J. T. (2016) · Journal of Attention Disorders · doi:10.1177/1087054716646452 · Cited by 70
Attention-Deficit/Hyperactivity Disorder
Leung, A. K. C., & Hon, K. E. (2016) · Advances in Pediatrics · doi:10.1016/j.yapd.2016.04.017 · Cited by 69
Karaca, S., Saleh, A., Canan, F., & Potenza, M. N. (2016) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-016-9660-8 · Cited by 75
Cardiovascular Effects of ADHD Therapies
Torres-Acosta, N., O’Keefe, J. H., O’Keefe, C. L., & Lavie, C. J. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.081 · Cited by 65
Chang, J. P., & Su, K. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.4.469 · Cited by 74
ADHD and hyperkinetic disorder
Sonuga‐Barke, E. J. S., & Taylor, E. (2015) · Rutter's Child and Adolescent Psychiatry · doi:10.1002/9781118381953.ch55 · Cited by 62
Barragán, E., Breuer, D., & Döpfner, M. (2014) · Journal of Attention Disorders · doi:10.1177/1087054713518239 · Cited by 70
Restriction and Elimination Diets in ADHD Treatment
Nigg, J. T., & Holton, K. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.05.010 · Cited by 60
Yan, S., Cao, H., Gu, C., Ni, L., Tao, H., Shao, T., Xu, Y., & Tao, F. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0131-0 · Cited by 60
Messamore, E., & McNamara, R. K. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0196-5 · Cited by 63
Puri, B. K., & Martins, J. G. (2014) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.01.004 · Cited by 56
Cornu, C., Mercier, C., Ginhoux, T., Masson, S., Mouchet, J., Nony, P., Kassaï, B., Laudy, V., Berquin, P. C., Franc, N., et al. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1058-z · Cited by 53
Gabbay, V., Freed, R. D., Alonso, C. M., Senger, S., Stadterman, J., Davison, B. A., & Klein, R. G. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11596 · Cited by 57
Arnold, L. E., Young, A. S., Belury, M. A., Cole, R. M., Gracious, B., Seidenfeld, A. M., Wolfson, H. L., & Fristad, M. A. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0123 · Cited by 53
Fuentes-Albero, M., Martínez, M., & Cauli, O. (2019) · Brain Sciences · doi:10.3390/brainsci9050120 · Cited by 51
Gillies, D. M., Leach, M., & Algorta, G. P. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007986.pub3 · Cited by 56
Nutritional Supplements for the Treatment of ADHD
Bloch, M. H., & Mulqueen, J. M. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.05.002 · Cited by 59
Self-citationLopresti, A. L. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-015-0170-5 · Cited by 49
Role of long-chain omega-3 fatty acids in psychiatric practice
McNamara, R. K., & Strawn, J. R. (2013) · PharmaNutrition · doi:10.1016/j.phanu.2012.10.004 · Cited by 51
Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment
Kiliaan, A. J., & Königs, A. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s68652 · Cited by 50
The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says
Lange, K. W., Hauser, J., Lange, K. M., Makulska-Gertruda, E., 中村由紀子, Reißmann, A., Sakaue, Y., Takano, T., & Takeuchi, Y. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0762-1 · Cited by 51
Milte, C. M., Parletta, N., Buckley, J. D., Coates, A. M., Young, R. M., & Howe, P. R. C. (2013) · Journal of Attention Disorders · doi:10.1177/1087054713510562 · Cited by 46
Psychosocial Interventions in Attention-Deficit/Hyperactivity Disorder
Antshel, K. M. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.08.002 · Cited by 56
Neurofeedback for Attention-Deficit/Hyperactivity Disorder
Westwood, S. J., Aggensteiner, P.-M., Kaiser, A., Nagy, P., Donno, F., Merkl, D., Balia, C., Goujon, A., Bousquet, E., Capodiferro, A. M., et al. (2024) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.3702 · Cited by 56
Attention Deficit Hyperactivity Disorder in Preschool-Age Children
Tandon, M., & Pergjika, A. (2017) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2017.02.007 · Cited by 46
Dervola, K.-S. N., Roberg, B., Wøien, G., Bogen, I. L., Sandvik, T., Sagvolden, T., Drevon, C. A., Johansen, E. B., & Walaas, S. I. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-56 · Cited by 44
Hess, J. L., Akutagava-Martins, G. C., Patak, J. D., Glatt, S. J., & Faraone, S. V. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.242 · Cited by 42
Ohki, C. M. Y., Grossmann, L., Alber, E., Dwivedi, T., Berger, G. E., Werling, A. M., Walitza, S., & Grünblatt, E. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00999-9 · Cited by 41
Attention-Deficit/Hyperactivity Disorder
Arnold, L. E., Hurt, E. A., & Lofthouse, N. (2013) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2013.03.001 · Cited by 42
Dietary DHA, bioaccessibility, and neurobehavioral development in children
Cardoso, C. L., Afonso, C. M., & Bandarra, N. M. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1338245 · Cited by 44
Treatment of pediatric acute-onset neuropsychiatric disorder in a large survey population
Calaprice, D., Tona, J., & Murphy, T. K. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0101 · Cited by 41
Fish, Shellfish, and Children’s Health: An Assessment of Benefits, Risks, and Sustainability
Bernstein, A. S., Oken, E., de Ferranti, S. D., Lowry, J. A., Ahdoot, S., Baum, C. R., Bole, A., Byron, L. G., Landrigan, P. J., Marcus, S. M., et al. (2019) · PEDIATRICS · doi:10.1542/peds.2019-0999 · Cited by 41
Zeng, Y., Tang, Y., Tang, J., Shi, J. C., Zhang, L., Zhu, T., Xiao, D., Qu, Y., & Mu, D. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1560905 · Cited by 39
de Viteri, M. S., Hernández, M., Bilbao‐Malavé, V., Fernández‐Robredo, P., González‐Zamora, J., García‐García, L., Ispízua, N., Recalde, S., & García‐Layana, A. (2020) · Antioxidants · doi:10.3390/antiox9090828 · Cited by 39
Laird, M. J., Henao, J. J. A., Reyes, E. S., Stark, K. D., Low, G., Swanson, H. K., & Laird, B. D. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.04.381 · Cited by 38
A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders
lusarczyk, J., Trojan, E., Chwastek, J., Głombik, K., & Basta‐Kaim, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160219131357 · Cited by 37
van der Wurff, I. S. M., Meyer, B. J., & de Groot, R. H. M. (2017) · Nutrients · doi:10.3390/nu9050474 · Cited by 37
Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration?
Shirooie, S., Nabavi, S. F., Dehpour, A. R., Belwal, T., Habtemariam, S., Argüelles, S., Sureda, A., Daglia, M., Tomczyk, M., Sobarzo‐Sánchez, E., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.004 · Cited by 37
Trim the fat: the role of omega-3 fatty acids in psychopharmacology
Nasir, M., & Bloch, M. H. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319869791 · Cited by 38
Self-citationSearight, H. R., Robertson, K., Smith, T., Perkins, S., & Searight, B. K. (2012) · ISRN Psychiatry · doi:10.5402/2012/804127 · Cited by 41
Matsudaira, T., Gow, R. V., Kelly, J., Murphy, C., Potts, L. C., Sumich, A. L., Ghebremeskel, K., Crawford, M. A., & Taylor, E. A. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0052 · Cited by 43
Trastorno por déficit de atención e hiperactividad (TDAH) en adolescentes
Rodillo, B. E. (2015) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2015.02.005 · Cited by 80
ADHD Research in Arab Countries: A Systematic Review of Literature
Alkhateeb, J. M., & Alhadidi, M. S. (2016) · Journal of Attention Disorders · doi:10.1177/1087054715623047 · Cited by 36
Do Omega-3/6 Fatty Acids Have a Therapeutic Role in Children and Young People with ADHD?
Derbyshire, E. J. (2017) · Journal of Lipids · doi:10.1155/2017/6285218 · Cited by 36
Omega-3 and its domain-specific effects on cognitive test performance in youths: A meta-analysis
Emery, S., Häberling, I. S., Berger, G. E., Walitza, S., Schmeck, K., Albert, T., Baumgartner, N., Strumberger, M. A., Albermann, M., & Drechsler, R. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.016 · Cited by 39
Metadata
- Authors
- Bloch, M. H., & Qawasmi, A.
- Affiliations
- Yale University (US)
- Al-Quds University (PS)
- Corresponding author
- Bloch, Michael H.
- ORCID
- Bloch, Michael H.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 50
- Issue
- 10
- Pages
- 991-1000
- ISSN
- 0890-8567 (ISSN-L)
- PMC
- PMC3625948
- OpenAlex
- W2016086054
- Semantic Scholar
- f2c54a2404c193896c22b8342c2fc366c28f311c
- Cited by
- 417
- References
- 48
- Citations by year
- 2026: 15 · 2025: 15 · 2024: 21 · 2023: 17 · 2022: 15 · 2021: 18 · 2020: 77 · 2019: 26 · 2018: 32 · 2017: 26 · 2016: 36 · 2015: 36 · 2014: 37 · 2013: 25 · 2012: 19
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (K23MH091240, R25MH077823)
- National Center for Research Resources (UL1RR024139)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
- Keywords
- omega-3 fatty acids, attention deficit hyperactivity disorder, children, eicosapentaenoic acid, dietary supplementation, ADHD symptom severity, cell membrane fluidity, phospholipid composition, non-pharmacological treatment
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Child, Humans, Eicosapentaenoic Acid, Fatty Acids, Omega-3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
